We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $8.76B
1-Year Est. Return 23.12%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+23.12%
3 Year Est. Return
+69.23%
5 Year Est. Return
+84.02%
10 Year Est. Return
+273.29%
AUM
$3.62B
AUM Growth
+$109M
Cap. Flow
+$29.8M
Cap. Flow %
0.82%
Top 10 Hldgs %
13.63%
Holding
1,787
New
81
Increased
723
Reduced
742
Closed
106

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$7.8M
2
DNB
Dun & Bradstreet
DNB
+$6.42M
3
PNC icon
PNC Financial Services
PNC
+$6.23M
4
PEP icon
PepsiCo
PEP
+$5.76M
5
DIS icon
Walt Disney
DIS
+$4.56M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Healthcare 15.13%
3 Technology 14.47%
4 Industrials 12.84%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBCF icon
1276
Seacoast Banking Corp of Florida
SBCF
$3.4B
$60K ﹤0.01%
2,510
CARB
1277
DELISTED
Carbonite Inc
CARB
$60K ﹤0.01%
2,758
GOLF icon
1278
Acushnet Holdings
GOLF
$5.97B
$59K ﹤0.01%
2,992
+582
+24% +$10.9K
KE
1279
Kimball Electronics
KE
$614M
$59K ﹤0.01%
3,254
+1,985
+156% +$34.2K
CASH icon
1280
Pathward Financial
CASH
$1.92B
$58K ﹤0.01%
1,962
DGX icon
1281
Quest Diagnostics
DGX
$25.6B
$58K ﹤0.01%
517
-7,033
-93% -$744K
SCHM icon
1282
Schwab US Mid-Cap ETF
SCHM
$14.7B
$58K ﹤0.01%
3,636
+42
+1% +$667
STAG icon
1283
STAG Industrial
STAG
$7.44B
$58K ﹤0.01%
2,086
+34
+2% +$910
UFPI icon
1284
UFP Industries
UFPI
$5.13B
$58K ﹤0.01%
2,001
+54
+3% +$1.64K
UTMD icon
1285
Utah Medical Products
UTMD
$231M
$58K ﹤0.01%
808
+463
+134% +$30.5K
NVRO
1286
DELISTED
NEVRO CORP.
NVRO
$58K ﹤0.01%
776
+553
+248% +$44.3K
AGO icon
1287
Assured Guaranty
AGO
$3.72B
$57K ﹤0.01%
1,384
-15
-1% -$591
NE
1288
DELISTED
Noble Corporation
NE
$57K ﹤0.01%
15,880
+1,676
+12% +$7.71K
CHUBK
1289
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$57K ﹤0.01%
3,295
+2,063
+167% +$34.1K
FNSR
1290
DELISTED
Finisar Corp
FNSR
$57K ﹤0.01%
2,194
EXEL icon
1291
Exelixis
EXEL
$13.7B
$56K ﹤0.01%
+2,267
New +$48K
GL icon
1292
Globe Life
GL
$14.4B
$56K ﹤0.01%
727
-84
-10% -$6.39K
SCHB icon
1293
Schwab US Broad Market ETF
SCHB
$43.9B
$56K ﹤0.01%
5,790
+96
+2% +$927
OCLR
1294
DELISTED
Oclaro Inc.
OCLR
$56K ﹤0.01%
5,973
D icon
1295
Dominion Energy
D
$60.1B
$55K ﹤0.01%
710
-470
-40% -$36.9K
SLGN icon
1296
Silgan Holdings
SLGN
$4.37B
$55K ﹤0.01%
1,720
+18
+1% +$555
TEN
1297
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$55K ﹤0.01%
949
-43
-4% -$2.48K
AIV.PRA
1298
DELISTED
Apart. Invst and Mgt Co
AIV.PRA
$55K ﹤0.01%
2,039
MUR icon
1299
Murphy Oil
MUR
$5.51B
$54K ﹤0.01%
2,103
+244
+13% +$6.37K
TRIP icon
1300
TripAdvisor
TRIP
$1.67B
$54K ﹤0.01%
1,403
-1,213
-46% -$50.2K

Similar funds

Oppenheimer Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Oppenheimer Asset Management held 1,787 positions worth $3.62B, up 3.1% from $3.51B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q2 2017 filing shows 81 new, 723 increased, 742 reduced and 106 closed positions. Its largest new stake was Evolent Health: 58,930 shares worth $1.49M. The largest sale was Microsoft, an estimated $7.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • Oppenheimer Asset Management's largest Q2 2017 buy was Evolent Health: 58,930 shares worth $1.49M.
  • Oppenheimer Asset Management added most to Johnson Controls International in Q2 2017, an estimated $9.09M increase.
  • Oppenheimer Asset Management's biggest Q2 2017 reduction was Microsoft, cutting an estimated $7.8M.
  • Oppenheimer Asset Management fully exited Nippon Telegraph & Telephone in Q2 2017, selling an estimated $3.36M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.62B portfolio in Q2 2017.
  • Oppenheimer Asset Management opened 81 new positions and closed 106 in Q2 2017.
  • Oppenheimer Asset Management's portfolio value rose 3.1% quarter-over-quarter to $3.62B.

Based on Oppenheimer Asset Management's 13F filing for Q2 2017, filed 9 Aug 2017.